Welcome to LookChem.com Sign In|Join Free

CAS

  • or

318276-72-1

Post Buying Request

318276-72-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

318276-72-1 Usage

General Description

6-bromocinnoline is a chemical compound that belongs to the class of cinnoline derivatives. It is an organic compound containing a cinnoline core with a bromine atom attached at the 6-position. 6-bromocinnoline has several potential applications in the field of pharmaceuticals and material science due to its unique structural and chemical properties. 6-bromocinnoline is widely used as a building block in the synthesis of various biologically active compounds and as a precursor for the preparation of polymers and organic materials. Its versatility and reactivity make it a valuable chemical in the development of new drugs and advanced materials. Additionally, its bromine substituent confers specific electronic and steric properties that can be exploited in various chemical reactions and processes.

Check Digit Verification of cas no

The CAS Registry Mumber 318276-72-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,1,8,2,7 and 6 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 318276-72:
(8*3)+(7*1)+(6*8)+(5*2)+(4*7)+(3*6)+(2*7)+(1*2)=151
151 % 10 = 1
So 318276-72-1 is a valid CAS Registry Number.
InChI:InChI=1/C8H5BrN2/c9-7-1-2-8-6(5-7)3-4-10-11-8/h1-5H

318276-72-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-bromocinnoline

1.2 Other means of identification

Product number -
Other names Cinnoline,6-bromo

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:318276-72-1 SDS

318276-72-1Relevant articles and documents

Discovery of cinnoline derivatives as potent PI3K inhibitors with antiproliferative activity

Chen, Yi,Deng, Mingli,Jia, Yu,Ling, Yun,Liu, Xiaofeng,Lu, Mingzhu,Tian, Chengze,Wu, Tianze,Yang, Chengbin,Yang, Yongtai,Zhou, Yaming

, (2021/07/28)

Cinnoline is a potential pharmacophore which has rarely been reported for uses as PI3K inhibitors. In this study, a series of cinnoline derivatives were developed as PI3K inhibitors and evaluated for enzymatic and cellular activities. Most compounds displ

Synthesis and SAR of indazole-pyridine based protein kinase B/Akt inhibitors

Woods, Keith W.,Fischer, John P.,Claiborne, Akiyo,Li, Tongmei,Thomas, Sheela A.,Zhu, Gui-Dong,Diebold, Robert B.,Liu, Xuesong,Shi, Yan,Klinghofer, Vered,Han, Edward K.,Guan, Ran,Magnone, Shayna R.,Johnson, Eric F.,Bouska, Jennifer J.,Olson, Amanda M.,Jong, Ron de,Oltersdorf, Tilman,Luo, Yan,Rosenberg, Saul H.,Giranda, Vincent L.,Li, Qun

, p. 6832 - 6846 (2007/10/03)

A series of heteroaryl-pyridine containing inhibitors of Akt are reported. The synthesis and structure-activity relationships are discussed, leading to the discovery of a indazole-pyridine analogue (Ki = 0.16 nM). These compounds bind in the ATP binding site, are potent, ATP competitive, and reversible inhibitors of Akt activity. No selectivity amongst the Akt isoforms is observed for this analogue, but there is good selectivity against an panel of other kinases. It is least selective for other members of the AGC family of kinases but is nonetheless 40-fold selective for Akt over PKA. The compound shows cellular activity and significantly slows tumor growth in vivo.

Kinase inhibitors

-

Page/Page column 27, (2010/01/31)

Compounds having the formula are useful for inhibiting protein kinases. Also disclosed are compositions which inhibit protein kinases and methods of inhibiting protein kinases in a patient.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 318276-72-1